Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (March 2026)
52 slides from Burjeel's investor presentation, March 2026
Slide 1: Investor Presentation
Investor Presentation A Leading Super-Specialty Healthcare Provider in the GCC March 2026
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 03 Investment 02 Highlights Strategic Priorities 04 Performance Update 01 At a Glance 05 Guidance 06 Appendix
Slide 4: At a Glance
01 At a Glance Leading Super-Specialty Healthcare Provider in the Gulf
Slide 5: Leading Super-Specialty Healthcare Provider in MENA
Leading Super-Specialty Healthcare Provider in MENA Expanding Market Presence UAE, Oman & KSA 115 15 Geographical Healthcare assets O&M projects presence incl. 20 hospitals1 in UAE & Africa1 7.0 million 1,784 1,776 Patients served2 Bed capacity1 Doctors1 Integrated Multi-Brand Network Premium Expats
Slide 6: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Hospital Medical Centers 1% Pharmacies Physiotherapy Dubai & centers 88% 2% Other 85% Abu Dhabi, 10% Northern Emirates Hospitals Al Dhafra & Al Ain Medical 4% Oman 9% Cente
Slide 7: Business Model
1 2 Business 1 Differentiating capabilities • • Model Level I & II Trauma Center Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 8: Integrated End-to-End Complex Care
5 Expanding geographically Oncology Multi-Organ Transplant Kidney & Liver Living & Deceased Immunotherapy Palliative Care Transplants Donation ABO-Incompatible Precision Diagnostics Nuclear Medicine Pediatric Transplants Cases Medical & Radiation Robotic Transplant Surgical Oncology Oncology Transpl
Slide 9: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in the Gulf
Slide 10: Strategic Priorities
5 Expanding geographically Ramp-up of Growth Assets Operational Excellence • Maximize utilization of the young • Strengthen multi-disciplinary care asset base to drive volume and centralized operations • Position Burjeel Medical City as • Advance medical innovation, the flagship complex-care hub edu
Slide 11: Strategic Growth Pillars
5 Expanding geographically Strategic Growth Pillars Ramp-up of Growth Assets Increasing Patient Yield Operational Excellence Geographic Expansion Group Revenue Patient Yield Group EBITDA Margin Healthcare Assets Low- Single 5.5bn Double Mid-Term Mid-Term Mid-Term ‘25 Digit CAGR Target ‘25 752 Digit
Slide 12: Investment Highlights
03 Investment Highlights Leading Super-Specialty Healthcare Provider in the Gulf
Slide 13: Investment Highlights
World-class super- Expanding geographically specialty care through high-return and driving patient yield growth low-CAPEX opportunities Accelerating Leading position in large, growing, & digitization resilient market to drive operational and medical excellence Well-invested multi- Cash-generative br
Slide 14: Super-Specialty Care Offering Driving Patient Yields
51 Expanding World-classgeographically super-specialty care Super-Specialty Care Offering Driving Patient Yields Unmatched Da Vinci Xi system Momentum in Scaling Maximizing Patient Growth & Yield Innovation & Expertise Multi-Organ & Bone Marrow Transplants Liver & Kidney Transplants 67 (100% success
Slide 15: Advancing Specialized Care Through Innovation
1 World-class super-specialty care Advancing Specialized Care Through Innovation Transforming Limb Restoration Recent Breakthroughs in Complex Care The Middle East’s First Osseointegration Clinic Revolutionary solution Global access at lower cost: for amputees: direct Comparable to US ($95k—$150k) b
Slide 16: Trust Fertility Center: Powering UAE's Fertility Strategy
1 World-class super-specialty care Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up Integral in Burjeel’s AED 58m 3,000+ 1,900+ ~50% Women’s Health Platform 2025 Total Unique Patient IVF, FET, & IUI Clinical Pregnancy Rate Revenue Volumes Cycles Initiated (above global av
Slide 17: Robust Talent Investments Powering Innovation & Research Capabilities
1 World-class super-specialty care Robust Talent Investments Powering Innovation & Research Capabilities Highly skilled and growing talent pool UAE’s Premier Research Hub: Advancing Science & Innovation +830 Doctors Axiom Space Partnership: Successfully completed an in-orbit research on 1,744 1,776
Slide 18: Market Leading Position in Large, Growing, & Resilient Market
2 Market Leading Position Market Leading Position in Large, Growing, & Resilient Market 2023E Total Healthcare Expenditure in the GCC $99bn 159 GCC market size 136 $84bn UAE & Oman & KSA market size 99 109 118 1.6x 21% Burjeel Holdings’ $26bn private hospital market share in UAE & Oman the UAE (2023
Slide 19: Differentiated Growth Strategy Driving Specialized Care Across Network
2 Market Leading Position Differentiated Growth Strategy Driving Specialized Care Across Network Large, Growing, & Resilient Addressable Market Anchor Burjeel as the regional O&M leader, delivering specialist support and operational excellence across the GCC and Africa. $99bn 21% GCC market size Bur
Slide 20: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception AED 5.3bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints — driving revenue, brand
Slide 21: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Diverse brand portfolio and network Brands creates favourable negotiating position with insurance payers Payer Mix Revenue6 Assets1 12 Hospitals2 2 Hospitals 4 Hospitals 2 Hospitals 10 Medical centers3
Slide 22: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset Maturity Split for Hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 30% Growth — high FY 2025 Mature Burjeel Hospital, Abu Dhabi Growth Burjeel Medical
Slide 23: Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential
5 Expanding geographically Multi-Pronged Expansion Strategy: Unlock Solid Growth Potential Key region of focus Expansion strategy pillars KSA to drive our geographic expansion Expanding World-Class Healthcare Network 1 Across Emerging UAE Communities Capital-light expansion into Africa, through O&M
Slide 24: Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline
5 Expanding geographically Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline 2026 Expected Impact 2027- 2028 at Maturity 1 1 1 1 AED 1.5 bn Revenue Hospital Fertility Clinic Hospital Fertility Clinic Mid-20s 1 3 1 3 EBITDA Margin Day Surgery Medical Day Surgery Medical Ce
Slide 25: Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships
5 Expanding geographically Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships Approach Scope of Services 15% Contribution to FY’25 Partnering with Hospital O&M ER/Critical Care O&M 365k+ Net Profit Ministries of Health, Comprehensive hospital 24/7 Emergency and ICU Annual Patien
Slide 26: Digital & AI Platform: Driving Structural Efficiency, Margin Expansion & Care Excellence
6 Accelerating digitization Digital & AI Platform: Driving Structural Efficiency, Margin Expansion & Care Excellence Digital Core Infrastructure • Unified EMR Embedded AI Across the Care Continuum • Real-time KPIs • Standardized workflows Oracle Command Center IP/OP AI & Clinical Intelligence AI-dri
Slide 27: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 28: Management
8 Commitment to ESG 19.7 Strong Leadership with Well-Established Low Risk As of June 2025 Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A N B A A N 1 Female Board B Business Developm
Slide 29: Strategic Pillars – ESG Framework
8 Commitment to ESG 19.7 Strategic Pillars – ESG Framework Low Risk As of June 2025 System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives p
Slide 30: FY 2025 ESG Highlights
8 Commitment to ESG 19.7 FY 2025 ESG Highlights Low Risk As of June 2025 System Community Governance Environment 95% 87% Zero +2% Employee Inpatient Data breaches, corruption or Electricity satisfaction score satisfaction score bribery and whistleblowing cases Consumption 57% 100% 4 of 7 -10% Women
Slide 31: Performance Update
04 Performance Update Leading Super-Specialty Healthcare Provider in the Gulf
Slide 32: 2025: Built on Strength – Guidance Delivered
5 Expanding geographically 2025: Built on Strength – Guidance Delivered Full-Year Highlights Transition from Build-Out to Performance 2025 YoY Patients 7.0m +8% Revenue AED 5.5bn +10% 2024 2025 Mid-Term Investment Execution & Disciplined Phase Stabilization Value Creation EBITDA AED 1.1bn +20% Net P
Slide 33: 2025: A Momentous Year – Platform Expansion & Breakthroughs in Medical Excellence
2025: A Momentous Year – Platform Expansion & Breakthroughs in Medical Excellence Expanding Advancing Scaling Embedding Integrated Network Complex Care Clinical Excellence Medical Innovation Hospitals & Specialized GCC’s First & Only Day Care Centers Osseointegration 31 UAE’s Youngest Organ Pediatri
Slide 34: Accelerating Market Penetration Driving Record Quarterly Patient Volumes
Accelerating Market Penetration Driving Record Quarterly Patient Volumes Group Outpatient Footfall, k Group Inpatient Footfall, k % OP utilisation % bed occupancy • Total patient footfall grew 8.4% YoY to over • Inpatient footfall increased 11.7% in FY’25 7 million in FY’25 and accelerated to and 9.
Slide 35: Hospitals Powering Profit Growth While Medical Centers Scale Rapidly
Hospitals Powering Profit Growth While Medical Centers Scale Rapidly Group Revenue, AED m Group EBITDA, AED m YoY EBITDA margin YoY 1,388 • Total revenue increased 6.3% in Q4’25, • Group EBITDA grew 35.4% YoY in Q4’25, driven by new facility ramp-up and a with margin up by 4.4pp. +6.3% rebound in pa
Slide 36: Burjeel Medical City Scaling Volumes With Delivering Strong Margin Expansion
5 Expanding geographically Burjeel Medical City Scaling Volumes With Delivering Strong Margin Expansion Patients, k Revenue, AED m1 EBITDA, AED m1 % bed occupancy % EBITDA margin 68% 60% 62% 61% 15.3% 18.3% 15.9% 18.7% +18.3% +7.1% +26.1% 638 1,290 241 1,205 539 192 +15.6% (3.3%) +15.5% 175 326 315
Slide 37: Margin Normalization Progressing Through Asset Maturity & Cost Discipline
Margin Normalization Progressing Through Asset Maturity & Cost Discipline Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 84.4% 82.0% 81.4% 79.4% 15.9% 20.3% 13.4% 11.5% 12.7% 11.4% +50 (41) 2.2% 2.1% 3.3% (7) 2.5% +83 (2) (9) 282 25.0% 24.9% 23.0% 19.9% 208 43.9% 44.
Slide 38: Robust Free Cash Flow Generation Reflecting Strong EBITDA Growth & Disciplined Investment
Robust Free Cash Flow Generation Reflecting Strong EBITDA Growth & Disciplined Investment Net Cash from Operating Activities, AED m Total Investments, AED m % FCF conversion1 Growth CAPEX Maintenance CAPEX Acquisitions & Investments in Associates 48% +81 41% (262) 716 +142 131 500 (37) (19) (3) 402
Slide 39: AI-Enabled Claims Management & Insurance Alignment Driving Working Capital Normalization
AI-Enabled Claims Management & Insurance Alignment Driving Working Capital Normalization AI-Driven Centralized Claims Management Claims Submission Process (Integrated with Oracle) 100+ CDI professionals Medical Coding Training & Education 1000+ Initial Submission Resubmission Payment Medical Claim P
Slide 40: Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation
Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation AED m 31 December 2025 31 December 2024 Debt Maturity as of 31 December 2025 Bank balances and cash 281 238 Interest-bearing loans and borrowings 1,918 1,208 526 Bank overdraft — — 414 346 340 Bank debt1 1,918 1,208 Net debt 1,
Slide 41: Strong Profitability Momentum With Continued Commitment to Dividends
Strong Profitability Momentum With Continued Commitment to Dividends Net Profit Evolution, AED m Commentary % net profit margin • Full-year net profit increased 39.5% YoY to AED 503 million, with net margin improving to 7.0% 9.0% 11.9% 7.2% 9.2% 4.1% 10.1% 9.2%, driven by strong operating leverage,
Slide 42: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in the Gulf
Slide 43: Mid-Term Outlook & Guidance
Mid-Term Outlook & Guidance Network Expansion Profitability 18 Healthcare Assets: 2 Hospitals — Dubai, 4 Day Surgery Centers — Group EBITDA margin expected to expand to the low-20s UAE, 6 Medical Centers — UAE, 2 Fertility Clinics — Al Ain and range on a blended basis, driven by asset ramp-up, scale
Slide 44: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in the Gulf
Slide 45: A Proven Track Record of Scale and Leadership
A Proven Track Record of Scale and Leadership 2007-2010 2015 2017 2019 2021 2023 2025 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East Launched Al Muderis in 2007 under LLH Launch invasive surgeries and alternativ
Slide 46: Transforming Cancer Care: The UAE's Leading National Network
5 Expanding geographically Transforming Cancer Care: The UAE’s Leading National Network Burjeel Cancer Institute Diversified Referral Pathways Clinical Governance (Burjeel Medical City) Strengthening Oncology Access & Research Hub for high-end specialized oncology treatments Pathology, AI & Molecula
Slide 47: Advancing Women & Children's Healthcare Offering
Advancing Women & Children’s Healthcare Offering Partnered with the "Father of Fetal The UAE’s largest fertility center, Medicine," to provide fetal care for high- which commenced operations in risk pregnancies. First in MENA to September 2024 and became fully perform in-utero spina bifida repair. o
Slide 48: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘23-31E of GDP1 Healthcare expenditure as % of GDP2 +5% +3% +3% 5% 11% 17% +2% CAGR ‘24-29E +32% CAGR ‘24-29E UAE Oman KSA GCC UK USA
Slide 49: Q4'25 & FY'25 Financial Summary
Q4’25 & FY’25 Financial Summary Group Group Income Statement Summary Financial Performance by Segment AED m Q4’25 Q4’24 FY’25 FY’24 AED m Q4’25 Q4’24 2025 2024 Revenue 1,388 1,305 5,486 5,010 Revenue 1,388 1,305 5,486 5,010 Inventories consumed (276) (327) (1,261) (1,246) Hospitals2 1,222 1,181 4,84
Slide 50: FY'25 Financial Summary
FY’25 Financial Summary Balance Sheet Summary AED m 31 Dec 2025 31 Dec 2024 Change AED m 31 Dec 2025 31 Dec 2024 Change Shareholders' equity Non-current assets Share capital 521 521 – Property and equipment 2,127 1,932 +195 Shareholder’s contribution 4 4 – Intangible assets 20 16 +4 Other reserves 3
Slide 51: FY'25 Financial Summary
FY’25 Financial Summary Cash Flow Summary AED, m FY’25 FY’24 Change, % Operating activities Net Profit for the Period Before Tax 541 399 +35.5% Non-cash adjustments 711 630 +12.9% Working capital adjustments (677) (415) +63.0% Other (173) (114) +51.5% Net Cash, Operating activities 402 500 (19.5%) I
Slide 52: IR Contacts
IR Contacts March 2026 Sergei Levitskii Director of Investor Relations Investor Feedback Hotline sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 Engaging openly with our investors and analysts is a cornerstone of our approach. We’ve partnered with Closir to make sharing your feedback quick a
Burjeel Holdings — Investor Presentation (March 2026) on 6ix